NCT03763487 is a NA clinical trial of venous blood sampling in Celiac Disease, sponsored by University Hospital Hradec Kralove.

Who is sponsoring NCT03763487?

NCT03763487 is sponsored by University Hospital Hradec Kralove.

What drugs are being tested in NCT03763487?

Interventions in NCT03763487: venous blood sampling, spleen volumetry.

What condition does NCT03763487 study?

NCT03763487 studies Celiac Disease.

Is NCT03763487 still recruiting?

NCT03763487 is currently status unknown. Last updated 4 December 2018.

Last reviewed 2018-12-04 · How we verify

NCT03763487

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Aim of This Project is to Verify Whether a Depletion of B Cell Memory Subpopulation ("Marginal-zone-like") CD19 + IgD + CD27 + and CD19 + IgM + CD27 + is a Useful Indicator of Hyposplenism in Patients With Celiac Disease

Status unknown NA Last updated 4 December 2018

What this trial tests

NA trial testing venous blood sampling in Celiac Disease in 50 participants. Status unknown.

Timeline

1 June 2018

Primary endpoint
31 December 2018

31 December 2018

Quick facts

Lead sponsor	University Hospital Hradec Kralove
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	50
Start date	1 June 2018
Primary completion	31 December 2018
Estimated completion	31 December 2018
Sites	1 location across Czechia

Drugs / interventions tested

venous blood sampling
spleen volumetry

Conditions studied

Celiac Disease — all drugs for Celiac Disease →

Sponsor

University Hospital Hradec Kralove

Who can join

18 and older, any sex, with Celiac Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project is expected to confirm the hypothesis that hyposplenism in patients with celiac disease is not conditioned by a selective memory deficiency of B lymphocytes. Other objectives of project are: * determination of gliadin 33-mer in faecal and urine as indicators patient´s adherence to gluten-free diet * determination of citrulline in plasma as an indicator of the overall functional capacity enterocytes

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of venous blood sampling

Trials testing the same drug.

NCT04106401 — Intravascular Volumes in Hypoxia During Antarctic Confinement · NA · unknown

Other recruiting trials for Celiac Disease

Currently open trials in the same condition.

NCT07239336 — Study of DONQ52 in Active Celiac Disease · Phase 2 · recruiting
NCT07585669 — Effects of Omega-3 Fatty Acids on Inflammation and Gut Microbiota in Celiac Disease · NA · recruiting
NCT07063823 — A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease · Phase 1 · recruiting
NCT06982963 — Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease · Phase 2 · recruiting
NCT07177287 — The Effect of a Navigator Nurse- Supported Mobile Application Developed Based on the IMB Model on the Quality of Life of · NA · recruiting

Other University Hospital Hradec Kralove trials

Trials by the same sponsor.

NCT07415655 — Modulation of Cerebral Ischemia by Albumin · Phase 2 · not yet recruiting
NCT03644641 — The Influence of Prone Position for Spinal Surgery on Visual Acuity · NA · not yet recruiting
NCT06894927 — Hearing Screening in Adults Over 50 Years Old · NA · enrolling by invitation
NCT05399602 — The Role of Neurofilament Light (NfL) in Patients With Hydrocephalus · NA · completed
NCT06083233 — Role of Brain Specific Biomarkers in Hydrocephalus · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03763487 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital Hradec Kralove
Last refreshed: 4 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03763487.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing